Received Oct 28, 2025
| Type | Name | Manufacturer | Dose | Lot | Route / Site |
|---|---|---|---|---|---|
| ANTH | ANTHRAX (BIOTHRAX) | EMERGENT BIOSOLUTIONS | 4 | 300216A | IM / LA |
32 y/o healthy female, received AVA #4 when she was about 5-6 weeks pregnant. She suspected she was pregnant at the time and forgot to mention it to the staff and no screening form was provided prior to immunization. She had a very light positive home pregnancy test on 8/10/2025, and received AVA on 8/28/2025. EDC: 4/7/2026. She has had an episode of moderate vaginal bleeding and was evaluated in the ED on 10/17. Her U/S and exam were normal, and the bleeding has since resolved. The IHD Info paper was emailed to her (When Pregnancy is Discovered..). I will follow her occasionally through her pregnancy and told her she can reach out at any time. Informed her pregnancy registry is no longer active. She has the information for the Research Center. Phone:. Email: mil if she would like to contact them regarding any additional follow up from the registry. Processes leading up to the event were reviewed. A PSR was filed at that time. Additional information for Item 19: or subchorionic hematoma, and normal appearing cervix.
no
no
No, but was using tretinoin 0.025% topical gel until 7/11/2025
NKDA
ED workup demonstrated viable pregnancy negative for visualized intrauterine abnormalities, with TVUS showing +FM, +fetal cardiac, anterior placenta without evidence of previa (con't